Attenuated 5‐hydroxytryptamine receptor‐mediated responses in aortae from streptozotocin‐induced diabetic rats

10.1016/0165-6147(89)90197-1

10.1016/0014-2999(90)90370-L

10.1038/305627a0

COHEN M.L., 1981, Evidence for 5‐HT2 receptors mediating contraction in vascular smooth muscle, J. Pharmacol. Exp. Ther., 218, 421

10.1111/j.1476-5381.1985.tb08948.x

10.1016/0165-6147(87)90047-2

10.1111/j.1476-5381.1991.tb12528.x

10.1159/000138069

10.1111/j.1476-5381.1987.tb10282.x

10.1007/BF00634259

10.1111/j.1476-5381.1992.tb14389.x

10.1007/BF00172788

10.1111/j.1476-5381.1989.tb11993.x

LEYSEN J.E., 1982, [3H]ketanserin (R 41 468), a selective 3H‐ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role, Mol. Pharmacol., 21, 301

MARTIN W., 1986, Depression of contractile responses in rat aorta by spontaneously released endothelium‐derived relaxing factor, J. Pharmacol. Exp. Ther., 237, 529

10.1016/0010-468X(83)90031-4

10.1016/0003-2697(80)90515-1

NAKAKI T., 1985, Phasic and tonic components in 5‐HT2 receptor‐mediated rat aorta contraction: participation of Ca++ channels and phospholipase C, J. Pharmacol. Exp. Ther., 234, 442

OWEN M.P., 1979, Alterations in vascular smooth muscle sensitivity to vasoactive agents by streptozotocin induced diabetes, Proc. West. Pharmacol., 22, 363

10.1016/0014-2999(86)90013-0

10.1016/0003-2697(73)90523-X

10.1097/00005344-199309000-00012

10.1016/0014-2999(90)94204-B

10.1016/0014-2999(91)90647-9

10.1111/j.1476-5381.1992.tb12754.x